A Guide To Pancreatic Cancer Clinical Trials
This actionable non-small cell lung cancer guide lays out the considerations when managing your diagnosis to help you with the process and to make sure no step is missed along the way.
The pancreas is a small gland located in the abdomen that helps control blood sugar and aids in digestion and begins when cells within the pancreas begin to grow out of control. Pancreatic cancer is an aggressive disease that over 57,000 people will be diagnosed with in 2020 alone. 10% of pancreatic cancer cases are diagnosed in early stages while more than half have already metastasized. Commont types of Pancreatic Cancer are:
- Small Cell Carcinomas
- Neuroendocrine Tumors
- Transitional Cell Carcinomas
- Enlarged Prostate Treatment
Trials Can Help
There are currently over 500 active pancreatic cancer clinical trials taking place in the United States. Participating in a clinical trial not only progresses much-needed research, but also gives patients access to these new innovative therapies years before the general population.
The new treatments investigated in today’s pancreatic cancer clinical trials are:
- Targeted therapies for new biomarkers
- Immunotherapy using new monoclonal antibodies
- Combinations of chemotherapies with other drugs
- New methods of surgery
At Massive Bio, our mission is to enable cancer patients to have equal access to cutting-edge therapies and clinical trials, regardless of their location and/or financial stability.
Our Artificial Intelligence (AI) powered Clinical Trial Matching System connects patients and their treating oncologists to clinical trials according to their unique cancer case.
We enlist dedicated staff to collect medical records and treatment history and match patients to eligible trials near their home. We provide full support throughout your enrollment process to ensure logistics are handled so you can concentrate on your health.